286 related articles for article (PubMed ID: 35163322)
1. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
[TBL] [Abstract][Full Text] [Related]
2. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.
Kim JS; Lee KB; Park JH; Sung SM; Oh K; Kim EG; Chang DI; Hwang YH; Lee EJ; Kim WK; Ju C; Kim BS; Ryu JM;
Ann Neurol; 2020 Feb; 87(2):233-245. PubMed ID: 31721277
[TBL] [Abstract][Full Text] [Related]
4. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
5. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
Yang X; Chu H; Tang Y; Dong Q
Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
[TBL] [Abstract][Full Text] [Related]
6. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
Huang Y; Gu S; Han Z; Yang Z; Zhong L; Li L; Wang R; Yan F; Luo Y; Borlongan C; Lu J
J Am Heart Assoc; 2023 Sep; 12(17):e029817. PubMed ID: 37655472
[TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke.
Peng T; Booher K; Moody MR; Yin X; Aronowski J; McPherson DD; Savitz SI; Kim H; Huang SL
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627321
[TBL] [Abstract][Full Text] [Related]
9. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
10. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
[TBL] [Abstract][Full Text] [Related]
12. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
13. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke.
Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG
Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512
[TBL] [Abstract][Full Text] [Related]
14. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
[TBL] [Abstract][Full Text] [Related]
15. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.
Liu R; Liu Q; He S; Simpkins JW; Yang SH
J Pharmacol Exp Ther; 2010 Mar; 332(3):1006-12. PubMed ID: 19952306
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
[TBL] [Abstract][Full Text] [Related]
19. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD
Hu Q; Manaenko A; Bian H; Guo Z; Huang JL; Guo ZN; Yang P; Tang J; Zhang JH
Stroke; 2017 Jun; 48(6):1655-1664. PubMed ID: 28495827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
